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Abstract
Background: Hypoxia affects myocardial oxygen supply resulting in subclinical cardiac dysfunction in obstructive
sleep apnea (OSA) patients, with cardiovascular complications being associated with increased oxidative burst (OB).
The aims of our study were to assess left ventricular (LV) dynamic myocardial deformation and diastolic reserve at
rest and upon exercise, along with OB determination in this patients subset.
Methods: Conventional echocardiography, Doppler myocardial imaging and LV 2D speckle tracking echocardiography
were performed in 55 OSA patients with preserved LV ejection fraction (EF) and 35 age and sex-comparable healthy
controls. Peripheral OB levels were evaluated by flow cytometry.
Results: Despite comparable LVEF, LV global longitudinal strain (GLS) was significantly reduced in OSA at rest (! 13.4 ±
3.8 vs ! 18.4 ± 3.3 in controls, P < 0.001) and at peak exercise (! 15.8 ± 2.6 vs ! 23.4 ± 4.3, P < 0.001). Systolic pulmonary
artery pressure (sPAP) and E/E! ratios increase during effort were higher in OSA than in controls (!sPAP 44.3% ± 6.4 vs
32.3% ± 5.5, P < 0.0001, and !E/E’ 87.5% ± 3.5 vs 25.4% ± 3.3, P < 0.0001, respectively). The best correlate of E/E! at peak
stress was peak exertion capacity (r = ! 0.50, P < 0.001). OB was also increased in OSA patients (P = 0.001) but, unlike
OSA severity, was not associated with LV diastolic dysfunction.
Conclusions: Evaluation of diastolic function and myocardial deformation during exercise is feasible through stress
echocardiography. OSA patients with preserved LVEF show subclinical LV systolic dysfunction, impaired LV systolic and
diastolic reserve, reduced exercise tolerance, and increased peripheral levels of OB. Therapy aimed at increasing LV
diastolic function reserve might improve the quality of life and exercise tolerability in OSA patients.
Keywords: Obstructive sleep apnea, Exercise echocardiography, 2D speckle tracking echocardiography, Diastolic
function, Oxidative burst
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Background
Obstructive sleep apnea (OSA) is characterized by re-
peated episodes of partial or complete upper airways
collapse, resulting in apnea and hypopnea events, inter-
mittent hypoxemia and frequent arousals [1]. OSA is an
increasing health problem, often associated with cardio-
vascular disorders, including left (LV) and right ventricu-
lar (RV) dysfunction, arterial hypertension, coronary
artery disease, heart failure, and arrhythmias [2, 3]. Re-
petitive hypoxia episodes adversely affect the interaction
between myocardial oxygen demand and supply, with
development of subclinical systolic dysfunction [4]. Fur-
thermore, hormonal and metabolic dysregulation, oxida-
tive burst (OB), systemic inflammation and mechanical
hemodynamic disturbances lead to LV remodeling and
diastolic dysfunction [5–8]. There is evidence of a con-
sistent relationship between OB and OSA [9]. OB has
been suggested as a marker of upper airway obstructive
episodes and hypoxemia causing local oropharyngeal in-
flammation [10], and has been associated with cardiovas-
cular complications [11, 12].
On this basis, we hypothesized that OSA patients with
preserved LV ejection fraction (LVEF) would have
dynamic abnormalities in LV myocardial deformation
and/or increased dynamic diastolic stiffness. The aims of
our study were to assess, by means of 2D speckle track-
ing echocardiography (2DSTE) and diastolic parameters,
LV myocardial deformation and diastolic function in-
dexes both at rest and during exercise, mainly focusing
on the systolic and diastolic reserve. Reproducibility of
2DSTE measurements was also assessed. In addition, we
evaluated peripheral levels of OB as we aimed to address




From October 2017 to May 2018, 55 consecutive pa-
tients affected by moderate-severe OSA, referred to
our Respiratory Medicine Division, were enrolled. Pa-
tients with a clinical history of concomitant lung dis-
ease (including chronic obstructive pulmonary disease,
bronchial asthma, interstitial lung diseases), coronary
artery disease, valvular heart disease, congestive heart
failure, arrhythmias, and pulmonary hypertension
were excluded. All OSA patients were not being
treated with continuous positive airway pressure
(CPAP). Thirty-five age- and sex-comparable healthy
subjects referred to our attention for a voluntary car-
diovascular screening were enrolled as controls. The
study was conducted in accordance with the amended
Declaration of Helsinki. The local Ethics committee
approved the study and all individuals gave written
informed consent.
OSA assessment
OSA diagnosis was performed with home overnight
cardiorespiratory polygraphy using a VitalNight data
acquisition and analysis system (AirLiquide Medical
System, Rangendigen, Germany) according to reference
guidelines [13]. Data were analysed by trained sleep phy-
sicians with more than 3-yr experience and OSA severity
was graded with the apnea/hypopnea index (AHI) ac-
cording to accepted criteria [13]. Nocturnal respiratory
failure (NRF) was defined if t90% was !30% or there was
at least one period of 5 min minimum with a SpO2 "
90% with a nadir of 85% during registration [14, 15]. t90
is the percentage of time spent with a SpO2 < 90%.
Lung function
Spirometry, lung volumes measurement and determin-
ation of the haemoglobin (Hb)-adjusted single-breath dif-
fusing lung capacity of the carbon monoxide (DLCOsb)
were performed using a computer-assisted spirometer
(Quark PFT 2008 Suite Version Cosmed Ltd., Rome, Italy)
according to international standards [16–18]. The 6min
walking test (6MWT) was performed by trained hospital
staff according to guidelines [19]. Arterial blood gas ana-
lysis at rest was also obtained.
Heart study
Standard trans-thoracic echocardiography, Doppler evalu-
ation and strain analysis were performed at rest and at
peak effort using market available equipment (Vivid E9 -
GE Healthcare, Milwaukee, WI, USA; MyLab Alpha
ESAOTE, Florence, Italy). All measurements were per-
formed at our Cardiology Unit and independently assessed
by two cardiologists expert in echocardiography, accord-
ing to current recommendations [20–22]. Rest echocardi-
ography: LV ejection fraction (EF) and LV global
longitudinal strain (GLS) were evaluated as systolic func-
tion indexes. LVEF was calculated using the Simpson bi-
plane method, from the apical 4- and 2-chamber views. A
biplane LVEF !52% for men and ! 54% for women were
considered normal [20]. For strain calculation, the endo-
cardial borders of the LV myocardial walls were traced by
a point-and-click approach, in the end-systolic frame of
the 2D images, from the apical 3-, 4-, and 2-chamber
views. The tracking algorithm followed the endocardium
during all the cardiac cycle. Basal, mid, and apical regions
of interest were created and segments that failed to track
were manually adjusted. Longitudinal strains for each of
18 segments were measured and LV GLS was calculated
as the mean strain of all the segments. The tracking
process and conversion to Lagrangian strains were per-
formed offline using dedicated software (EchoPAC PC 2D
strain, GE Healthcare, Milwaukee, WI, USA). We defined
impaired GLS as > # 20% (a less negative value reflects a
more impaired GLS) [20, 21]. The following diastolic
D’Andrea et al. BMC Pulmonary Medicine _#####################_ Page 2 of 9
function parameters were measured by pulsed wave (PW)
Doppler and tissue Doppler imaging (TDI), in apical 4-
chamber view: peak early (E) and late (A) diastolic vel-
ocity of the mitral inflow, E/A ratio, peak septal and
lateral early myocardial diastolic velocity (e!) and aver-
age E/e! ratio. The peak tricuspid regurgitation velocity
(TRV) was measured in multiple echocardiographic
windows. On the basis of the highest TRV obtained,
systolic pulmonary artery pressure (sPAP) was calcu-
lated through the Bernoulli’s principle: (4xTRV2) + right
atrial pressure (RAP). RAP was estimated by measuring
the diameter of the inferior vena cava and its respira-
tory motion. Left atrial volume index (LAVI) was
assessed through biplane area-length method, dividing
the left atrial volume by the body surface area (BSA).
Atrium acquisitions were made from the apical 4- and
2- chamber views. The presence of more than 2
between average E/e’ > 14, septal e’ < 7 cm/s or lateral
e’ < 10 cm/s, TRV > 2.8 m/s (sPAP> 36 mmHg), and
LAVI > 34 ml/m2, was considered expression of LV dia-
stolic dysfunction in subjects with normal LVEF [22].
Exercise stress echocardiography: Standard supine bi-
cycle exercise stress echocardiography was performed
with incremental steps of 25W every 2 min [23]. Pa-
rameters evaluated at peak exercise included LV GLS as
systolic function index, LV diastolic parameters (E,
septal and lateral e’ and average E/e’ ratio) and sPAP.
An increase in the E/e’ ratio and/or sPAP upon exercise
were considered expression of impaired LV diastolic
function reserve [23].
Oxidative burst determination
Oxidative burst of peripheral leukocytes was measured
with the Phagoburst BURSTEST™ (PHAGOBURST™, BD
Bioscences, La Jolla, CA, USA), according to the manu-
facturer’s instruction. Briefly, 100 !l of heparinized
whole blood was incubated with opsonized E.coli at
37 °C for 10 min. A sample without stimulus served as
negative background control. Dihydrorhodamine (DHR)
123 was added for 10 min to allow the conversion to
fluorescent rhodamine 123 upon reactive oxygen species
(ROS) production. After erythrocytes were removed and
washing, 200 !l of DNA staining solution was added for
10 min to exclude aggregation artifacts. Samples were
acquired with a FACS CANTO flow cytometer (BD Bio-
sciences, La Jolla, CA, USA). Analysis was performed
with the FACS DIVA software.
Statistical analysis
Statistical analyses were performed using a commercially
available package (SPSS, Rel. 21.0. 2016, SPSS Inc.,
Chicago, IL, USA). Variables are presented as mean ±
standard deviation (SD). Two-tailed t-test for paired
and unpaired data was used to assess changes be-
tween groups.
Linear regression analyses and partial correlation test
by Pearson’s method were used to assess univariate rela-
tions. The following variables were included into the
analysis: clinical parameters (age, heart rate, oxygen
Table 1 Demographics and clinical features, lung function
parameters, and sleep-related findings of the study population
Variable OSA Controls P-value
(n = 55) (n = 35)
Age (years) 54.9 ± 8.8 50.2 ± 5.4 NS
Gender, male sex 39 (71) 24 (68) NS
Smoking habit
Smokers 9 (16) 0 (0)
Former smokers 23 (42) 0 (0)
No smokers 23 (42) 35 (100)
Pack/yr 32.8 ± 24.6
BMI (Kg/m2) 32.9 ± 6.7 28.3 ± 4.7 < 0.01
Dyslipidemia (%) 10 (18) 0 (0)
Hypertension (%) 14 (25) 0 (0)
Diabetes (%) 12 (22) 0 (0)
Lung function parameters
FVC (%pred.) 85.4 ± 13.6 98 ± 12.5 < 0.001
FEV1 (%pred.) 87 ± 16.8 86 ± 13 NS
FEV1/FVC (%) 102.7 ± 15.4 84 ± 9.5 < 0.001
TLC (% pred) 85 ± 5.9 86 ± 3.8 NS
DLCOsb(% pred) 84.3 ± 16.1 86 ± 5 NS
pH 7.38 ± 0.3 7.39 ± 0.4 NS
PaO2 (mmHg) 84.7 ± 8.1 85.3 ± 6.2 NS
PaCO2 (mmHg) 39.8 ± 4.1 38.6 ± 4.5 NS
Lactates (mmol/L) 1.2 ± 1.4 1.1 ± 1.2 NS
HCO3! (mmol/L) 26.1 ± 1.6 25.2 ± 1.4 NS
6MWT mt 512.1 ± 175.1 568 ± 145.6 NS
Sleep-related events
TST (minutes) 358.4 ± 68.7 362 ± 64.5 NS
Supine time (%) 49.7 ± 33.8 41.2 ± 29.8 NS
AHI 46.3 ± 28.7 3.2 ± 1.2 < 0.0001
Supine AHI (events/hour) 41.4 ± 27 2.2 ± 2.4 < 0.0001
ODI 46 ± 30.7 3.3 ± 1.2 < 0.0001
t90 (%) 24 ± 22.2 0.4 ± 0.6 0.001
Nadir % SpO2 68.5 ± 11.5 83.2 ± 6.2 0.0001
Data are expressed as absolute number (%) or mean ± SD. Statistically
significant results (p < 0.05) are reported in bold
Abbreviations: BMI Body mass index, FVC Forced vital capacity, FEV1 Forced
expiratory volume in the 1st second, TLC Total lung capacity, DLCOsb Single
breath carbon monoxide lung diffusing capacity, PaO2 Oxygen arterial partial
pressure, PaCO2 Carbon dioxide arterial partial pressure, HCO3 Sodium
bicarbonates, 6MWT mt, Meters traveled during 6 min walking test, TST Total
sleep time, AHI Apnea/hypopnea index, ODI Oxygen desaturation index, t90%
Percentage of time spent with SpO2 < 90%, SpO2 Arterial oxygen saturation
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saturation, systolic blood pressure, diastolic blood pres-
sure, body mass index (BMI), risk factors, co-
morbidities); lung function, sleep-related and metabolic
parameters; standard echocardiographic and 2DSTE pa-
rameters. To identify significant independent determi-
nants of resting and dynamic LV diastolic function in
OSA patients, their individual association with clinical,
functional and echocardiographic variables was assessed
by multivariate analysis, using a bidirectional stepwise
regression. Variables included in our analysis were all
the variables significantly (p < 0.05) associated with the
explained variable by univariate analysis. Odds ratios
(OR) were calculated using a logistic regression method,
and Beta-coefficients were obtained by linear regression
method. Values of p < 0.05 were considered significant
for all analyses.
Receiver operating characteristic (ROC) curve analysis
was performed to select optimal cut-off values of echocar-
diographic parameters. Reproducibility of GLS measure-
ments was determined in all the subjects. Intra-observer
variability and inter-observer variability were examined
using the coefficient of variation (COV), defined as the
ratio of the standard deviation (") to the mean (!) (%),
and by Bland-Altman analysis. COV, 95% confidence in-
tervals (CIs), and percent errors were reported.
Results
Peripheral levels of oxidative burst are increased in OSA
patients
Our study population was composed of 90 subjects, in-
cluding 55 OSA patients and 35 healthy controls. Main
demographic and clinical characteristics are summarized
in Table 1. Lung function was preserved in both study
groups (Table 1), with the exception of forced vital cap-
acity that was slightly lower in OSA patients. Distribu-
tion of sleep-related respiratory events is reported in
Table 1. Thirty patients were suffering from severe OSA
(54%), while 21 (39%) had a concomitant condition of
NRF, as assessed by a t90 > 30% in all cases. In line with
previous observations [9–11], levels of OB were signifi-
cantly increased in OSA patients than in controls (Fig. 1).
OB was significantly higher in patients with a t90 > 30%,
with no differences according to the AHI.
LV systolic function is impaired at rest and at peak
exercise in moderate-severe OSA with a good
reproducibility of 2DSTE measurements
LVEF was similar in OSA and control cohorts, and pre-
served in both (Table 2). LV mass was mildly increased in
OSA with no significant difference in LV diameters in the
2 groups (Table 2). LV speckle tracking was obtainable at
rest in 95% of the total analysed segments. The remaining
5% segments were not considered due to a suboptimal
tracking score. In OSA patients, LV GLS was significantly
reduced at rest, this variation being statistically meaningful
in all segments analysed (Table 2, Fig. 2). Also LV GLS
increase upon exercise was lower as compared to controls
(Table 3).
Overall, we observed a good reproducibility of glo-
bal LV strain measurements in our study population,
similar to that reported for speckle-tracking-based
strain measures performed in selected samples – in-
cluding healthy young adults [20, 21]. The average
coefficients of variation were " 7% for the longitudinal
strain measures. For all analyzed measures, intra- and
intra-observer ICC values were ! 0.80 (Intra-observer
variability: COV: LV GLS: 5.37 (ICC 0.73); Bland-
Altman analysis: LV GLS (95% CI ± 1.5; percent error
3.2%). Inter-observer variability: COV: LV GLS: 7.22
(ICC 0.77); Bland-Altman analysis: LV GLS (95% CI ±
1.7; percent error 3.6%).
Fig. 1 Levels of oxidative burst in OSA patients and healthy controls. a Distribution of oxidative burst (OB), calculated as mean fluorescence
intensity (MFI), in OSA patients with respect to healthy volunteers; b Boxplot showing that peripheral levels of OB (MFI) are significantly increased
in OSA patients as compared to healthy volunteers; c Boxplot showing the distribution of OB (MFI) in OSA patients according to t90%. As
reported, OB levels are significantly increased in patients with t90 > 30%
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LV diastolic function is impaired at rest and at peak
exercise in moderate-severe OSA
E/e’ ratio, sPAP and LAVI at rest were all significantly
higher in patients affected by OSA as compared to
healthy controls; moreover, both septal and lateral e’
velocities were significantly lower in the former (Table 2,
Fig. 2). According to recent guidelines, a definite diastolic
dysfunction was present at rest in 19 OSA (34.5%) [22].
E/e’ increase during exertion was significantly higher
in patients affected by OSA when compared to controls;
sPAP increase (difference between peak exertion and
resting sPAP) also showed the same trend along with a
three-fold decrease of oxygen saturation (Table 3).
Exercise tolerance is reduced in moderate-severe OSA
During physical exercise, OSA patients showed a re-
duced tolerance with a lower maximal workload in
Watts (115.3 ± 25 vs 150.4 ± 35, p < 0.001) and oxygen
saturation level (92.3% ± 3.2 vs 97.2% ± 2.6, p < 0.01) as
compared to healthy controls (Table 2).
Resting and exercise-induced LV diastolic dysfunction is
associated with OSA severity but not with OB levels
Logistic regression analysis showed that arterial hyper-
tension (OR 2.67, 95% CI 1.74–5.61; p < 0.01), resting
LV GLS > # 15% (OR 3.3, 95% CI 2.34–4.15; p < 0.001)
and severe AHI (OR 2.96, 95% CI 1.92–4.91; p < 0.001)
were independently associated with LV diastolic dys-
function at rest.
At peak exercise, by linear regression analysis E/e’
ratio was directly related to peak exertion capacity
expressed in Watts (beta coefficient # 0.50, p < 0.001), to
blood lactates at rest (beta coefficient 0.36, p < 0.01), to
resting LV GLS (beta coefficient 0.46, p < 0.001), and to
the AHI (beta coefficient 0.42, p < 0.001) (Table 4). No
significant correlations were found with OB, BMI smok-
ing, and co-morbidities.
Discussion
OSA is frequently associated with adverse clinical out-
comes [1], including cardiovascular diseases [24–27]. In
the present study, we showed that OSA patients: (1)
have subclinical LV systolic dysfunction despite a pre-
served LV output, and a low contractile reserve as com-
pared to healthy controls; (2) have an impaired LV
diastolic reserve along with a reduced exercise tolerance;
(3) display higher levels of OB that are not correlated
with diastolic heart function.
In 2007, Gondi et al. reported that OSA was associated
with sleep-induced LV systolic longitudinal dysfunction,
as measured by pulsed wave Doppler and tissue Doppler
imaging (TDI) [28]. As TDI is technically limited by the
insonation angle of the ultrasound beam, we further
proved by 2DSTE, which is independent of the interro-
gation angle, that LV and RV early myocardial dysfunc-
tion occur in OSA patients and are associated with
disease severity [29]. The relationship between OSA and
LV systolic dysfunction is not surprising as OSA patients
Table 2 Left ventricle standard echo and 2D speckle tracking
echo measurements at rest and peak effort
Variable OSA Controls P-value
(n = 55) (n = 35)
Resting measurements
SpO2 (%) 94.7 ± 16.2 98 ± 1.6 < 0.01
IVSd (mm) 11.4 ± 1.8 9.1 ± 2.3 < 0.01
PWd (mm) 10.4 ± 1.6 8.7 ± 2.1 < 0.01
LVEDD (mm) 48.3 ± 3.9 47.2 ± 4.4 NS
LVESD (mm) 34.3 ± 3.6 32.4 ± 4.1 NS
LV mass index (g/m2) 52.8 ± 5.3 48.1 ± 3.4 < 0.01
Biplane LVEF (%) 56.5 ± 6.2 57.4 ± 5.5 NS
LV GLS (%) !13.4 ± 3.8 !18.4 ± 3.3 < 0.001
Mitral E velocity (cm/s) 0.9 ± 0.3 0.8 ± 0.4 NS
Mitral A velocity (cm/s) 0.7 ± 0.4 0.9 ± 0.3 NS
E/A ratio 1.2 ± 0.4 0.9 ± 0.4 < 0.01
Mitral septal e’ velocity (cm/s) 0.13 ± 0.02 0.16 ± 0.05 < 0.01
Mitrallateral e’ velocity (cm/s) 0.14 ± 0.03 0.17 ± 0.03 < 0.01
E/e’ ratio 8.2 ± 3.1 5.9 ± 2.8 < 0.01
LAVI (ml/m2) 32.4 ± 4.4 28.3 ± 5.1 < 0.01
sPAP (mmHg) 31.5 ± 7.8 21.3 ± 2.9 < 0.01
TAPSE (mm) 22.5 ± 3.3 24.5 ± 3.8 NS
Tricuspid S! velocity (cm/s) 13.3 ± 2.2 14.4 ± 3.1 NS
Peak effort measurements
SpO2 (%) 92.3 ± 3.2 97.2 ± 2.6 < 0.01
Exercise capacity (Watt) 115.3 ± 25 150.4 ± 35 < 0.001
Biplane LVEF (%) 62.3 ± 5.8 65.7 ± 6.8 NS
LV GLS (%) !15.8 ± 2.6 !23.4 ± 4.3 < 0.001
Mitral E velocity (cm/s) 1.1 ± 0.5 1.2 ± 0.6 NS
Mitral A velocity (cm/s) 0.9 ± 0.4 0.9 ± 0.3 NS
E/A ratio 1.2 ± 0.4 1.3 ± 0.5 < 0.01
Mitral septal e’ velocity (cm/s) 0.08 ± 0.02 0.18 ± 0.05 < 0.0001
Mitral lateral e’ velocity (cm/s) 0.07 ± 0.03 0.19 ± 0.03 < 0.0001
E/e’ ratio 15.4 ± 4.1 7.4 ± 2.8 < 0.0001
sPAP (mmHg) 45.5 ± 5.8 28.4 ± 4.2 < 0.001
TAPSE (mm) 26.4 ± 2.3 27.5 ± 5.8 NS
Tricuspid s’ velocity (cm/s) 16.4 ± 3.1 17.7 ± 4.1 NS
Data are expressed as mean ± SD. Statistically significant results (p < 0.05) are
reported in bold
Abbreviations: SpO2 Arterial oxygen saturation, IVSd Inter-ventricular septum
thickness at end diastole, PWd Posterior wall thickness at end diastole, LVEDD
Left ventricular end diastolic diameter, LVESD Left ventricular end systolic
diameter, LV Left ventricle, LVEF Left ventricular ejection fraction, LV GLS Left
ventricular global longitudinal strain, LAVI Left atrial volume index, sPAP
Systolic pulmonary artery pressure, TAPSE Tricuspid annular plane
systolic excursion
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experience repeated increases in LV after-load during
sleep, due to exaggerated negative intra-thoracic pres-
sure and intermittent hypoxia and arousals. Acute re-
peated increases in after-load can therefore result in LV
subclinical systolic dysfunction [29]. In this study, we
enrolled patients with moderate-severe OSA and healthy
controls with preserved LVEF and found an early
involvement of the LV myocardium in the former. Actu-
ally, despite LVEF, that is traditionally used as systolic
function parameter, was normal in OSA patients, we
found an impaired basal LV GLS, which is expression of
subclinical LV pump dysfunction. In addition, we also
found that strain increase during physical exercise in
OSA patients was lower if compared to healthy controls,
reflecting their low contractile reserve. Interestingly, we
previously detected that OSA patients have also a
Fig. 2 Left ventricular systolic and diastolic dysfunction in OSA patients. Two-dimensional echocardiography (a: apical four chamber view)
showing mild impairment of resting LV regional and global strain (mainly in the septal region, see arrow) (b) and significant diastolic dysfunction
assessed by transmitral flow pattern (c) and both lateral (d) and septal (e) pulsed Doppler tissue imaging
Table 4 Multivariate analysis model: correlation between E/e’
ratio at peak exercise with univariable clinical parameters
Variable Beta coefficient P-value
LV E/e’ at peak
exercise
Watts (at peak effort) ! 0.50 < 0.001
Blood lactates (at rest) 0.36 < 0.01
LV GLS (at rest) 0.46 < 0.001
AHI 0.42 < 0.001
Statistically significant results (p < 0.05) are reported in bold
Abbreviations: LV GLS Left ventricular global longitudinal strain, AHI
Apnea-hypopnea index
Table 3 Changes in echocardiographic parameters and oxygen
saturation in OSA and controls during effort
Variable OSA Controls P-value
(n = 55) (n = 35)
! sPAP (%) 44.3 ± 6.4 32.3 ± 5.5 < 0.001
! E/e’ ratio (%) 87.5 ± 3.5 25.4 ± 3.3 < 0.0001
! LV GLS (%) 15.8 ± 3.4 25.4 ± 4.1 < 0.001
! SpO2 (%) - 2.5 ± 3.3 !0.8 ± 2.8 < 0.01
Data are expressed as mean ± SD. Statistically significant results (p < 0.05) are
reported in bold
Abbreviations: sPAP Systolic pulmonary artery pressure, LV GLS Left ventricular
global longitudinal strain, SpO2 Arterial oxygen saturation
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subclinical RV dysfunction, and that RV GLS impair-
ment was associated with sPAP and disease severity [30].
Previous studies show that the prevalence of LV dia-
stolic dysfunction at rest among OSA patients varies
from 23 to 56%, depending on the sample size and the
method of diastolic function assessment [31–34]. In our
cohort we observed that, according to recent guidelines
[22], a definite diastolic dysfunction was present in the
34.5% of OSA patients at rest. Pathophysiological mech-
anisms underlying LV diastolic dysfunction in OSA have
been widely studied: repetitive hypoxemia/re-oxygen-
ation sequences, sympathetic bursts, renin-angiotensin-
aldosterone system activation, oxidative stress, systemic
inflammation, intra-thoracic pressure reduction and
trans-mural pressure increasing, all participate in the
development of LV hypertrophy and remodelling, and
hence of LV diastolic dysfunction [5–8].
To our knowledge this is the first study addressing the
LV diastolic performance both at rest and at peak
exercise in a selected population of OSA patients. In
middle-aged healthy subjects, the E/e! ratio does not
change significantly with exercise because of propor-
tional increases in both the mitral inflow and annular
velocities [35–38]. Conversely, in our series almost all
patients enrolled showed an increase of the E/e’ ratio,
that was significantly higher than in the control group.
This finding indicates an impairment of the LV diastolic
function reserve resulting in an increased LV filling pres-
sure during exercise [22, 39, 40]. In agreement with
these observations, also sPAP increase was significantly
higher in OSA than in healthy subjects. The mean sPAP
value in OSA patients was > 43 mmHg (as estimated by
a TRV > 3.1m/s), which is the echocardiography threshold
of abnormal diastolic stress according to international
guidelines [23]. The present study clearly underlines the
strong relation between E/e’ ratio and exercise tolerance
in OSA. Patients with a higher E/e’ ratio at peak exercise,
and hence a more impaired diastolic reserve, showed a re-
duced functional capacity highlighted by a lower maximal
workload and a reduced peak SpO2 level. The E/e’ ratio at
peak exercise also resulted significantly correlated to LV
GLS, to AHI, which reflects OSA severity, and to blood
lactates, which are suggestive of inadequate tissue perfu-
sion. These findings can be explained by the mentioned
pathological mechanisms responsible for myocardial re-
modelling and fibrosis. The latter provokes impairment in
both systolic and diastolic function, which can worsen
during exercise, leading to reduced functional capacity.
Our study has some limitations. First, it is a single-centre
study with a sample size too small to drive definitive
general conclusions concerning subclinical LV functional
impairment in OSA patients. Also, our findings cannot
necessarily be extrapolated to patients with mild disease.
Finally, despite we found no correlations between the
diastolic impairment during exercise and patients age, OB,
BMI, smoking and co-morbidities, we cannot definitely ex-
clude their contribution. Indeed, while we excluded OSA
patients with major heart and lung diseases, the prevalence
of cardiovascular risk factors, such as smoke, obesity,
dyslipidemia, diabetes, and hypertension, was still not negli-
gible in our patient cohort. Further studies in larger popula-
tions will certainly help to address their impact by ad hoc
sub-group analyses.
Conclusions
In conclusion, evaluation of diastolic function and myo-
cardial deformation during exercise is feasible through
stress echocardiography and provides valuable informa-
tion in predicting exercise capacity in a selected popula-
tion of moderate-severe OSA patients with preserved
LVEF. These patients show subclinical LV systolic dys-
function, impaired LV systolic and diastolic reserve, re-
duced exercise tolerance, and increased peripheral levels
of OB. A CPAP treatment and a therapy aimed at in-
creasing LV diastolic function reserve might improve the
quality of life and exercise tolerability in this target
population.
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